Literature DB >> 17194663

MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count.

David P Steensma1, Jonathan S C Caudill, Animesh Pardanani, Rebecca F McClure, Terra L Lasho, Ayalew Tefferi.   

Abstract

Discovery of a constitutively activating point mutation of the Janus kinase 2 (JAK2) receptor-associated tyrosine kinase in patients with polycythemia vera (PV) and other BCR/ABL-negative myeloproliferative disorders prompted many groups around the world to examine diverse subsets of patients with myeloid diseases for the prevalence of the JAK2 V617F mutation and its clinical and pathological associations.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17194663

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  4 in total

1.  Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.

Authors:  J M Raya; L Arenillas; A Domingo; B Bellosillo; G Gutiérrez; E Luño; M A Piñán; M Barbón; M L Pérez-Sirvent; M J Muruzábal; L Yánez; L García; A Lemes; J T Navarro; A Elosegi; M A Cortés; A Villegas; M A Durán; M Ardanaz; L Florensa
Journal:  Int J Hematol       Date:  2008-09-27       Impact factor: 2.490

2.  Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis.

Authors:  J Broséus; E Lippert; A S Harutyunyan; S Jeromin; E Zipperer; L Florensa; J D Milosevic; T Haferlach; U Germing; E Luño; S Schnittger; R Kralovics; F Girodon
Journal:  Leukemia       Date:  2014-01-30       Impact factor: 11.528

3.  A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction.

Authors:  Alessandro Pancrazzi; Paola Guglielmelli; Vanessa Ponziani; Gaetano Bergamaschi; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi
Journal:  J Mol Diagn       Date:  2008-07-31       Impact factor: 5.568

4.  The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.

Authors:  Junko H Ohyashiki; Masayuki Yoneta; Hisashi Hisatomi; Tamiko Iwabuchi; Tomohiro Umezu; Kazuma Ohyashiki
Journal:  BMC Med Genet       Date:  2012-01-17       Impact factor: 2.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.